C. Ichim

发表

Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy

C. Ichim, Christine V Ichim, 2005, Journal of Translational Medicine.

Generation of high-titer viral preparations by concentration using successive rounds of ultracentrifugation

R. Wells, C. Ichim, 2011, Journal of Translational Medicine.

Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology.

R. Wells, A. Schuh, C. Ichim, 2006, Leukemia research.

Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

M. Berk, C. Ichim, S. Brook, 2001, International clinical psychopharmacology.

First among equals: The cancer cell hierarchy

R. Wells, C. Ichim, 2006, Leukemia & lymphoma.

The Orphan Nuclear Receptor EAR-2 (NR2F6) is a Leukemia Oncogene and Novel Regulator of Hematopoietic Stem Cell Homeostasis and Differentiation

C. Ichim, 2012 .

Kinase‐Independent Mechanisms of Resistance of Leukemia Stem Cells to Tyrosine Kinase Inhibitors

C. Ichim, Christine Victoria Ichim, 2014, Stem cells translational medicine.

Automated and Continuous Monitoring of Animal Welfare through Digital Alerting.

L. Schaevitz, C. Ichim, E. Defensor, 2020, Comparative medicine.

The orphan nuclear receptor EAR-2 (NR2F6) inhibits hematopoietic cell differentiation and induces myeloid dysplasia in vivo

R. Wells, C. Robertson, C. Ichim, 2018, Biomarker Research.

The orphan nuclear receptor Ear-2 (Nr2f6) is a novel negative regulator of T cell development.

R. Wells, C. Ichim, J. Zúñiga-Pflücker, 2014, Experimental hematology.